Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Targeted Drug Delivery for Cancer Associated Pain

NCT05674240 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT05674240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05674240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Targeted Drug Delivery for Cancer Associated Pain
Lead sponsor
Wake Forest University Health Sciences
Phase
Observational
Overall status
Completed
Start date
December 6, 2022
Completion date
March 20, 2026
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer associated pain, cancer pain, chronic pain, neuropathic pain